QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1M Capital Tranche to Refined Resin Technologies
FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that it has advanced the second tranche of capital, $1 million, to its investee company Refined Resin Technologies Inc. Refined Resin is using the series of tranches to implement its three-phase development strategy to operationalize its legally zoned, state-of-the-art medical cannabis extraction laboratory. Presently, Refined Resin has placed deposits and has funds in reserve to purchase all the essential equipment to start production once installed. The extraction facility is anticipated to be in commercial operation by late 2018 or early 2019.…